BIOCON BIOLOGICS
Biocon Biologics is a fully-integrated pure-play biosimilars organization globally engaged in developing high-quality, affordable biosimilars aimed at expanding patient access to cutting-edge therapies. It develops and commercializes a differentiated portfolio of novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets, as well as, generic formulations in the U.S. and Europe. The company is driven by a belief that the pharmaceutical industry has a humanitarian responsibility to provide essential drugs to patients who are in need and to do so with the power of innovation.
BIOCON BIOLOGICS
Industry:
Biotechnology
Founded:
1978-11-29
Address:
Bangalore, Karnataka, India
Country:
India
Website Url:
http://www.biocon.com
Total Employee:
5001+
Status:
Active
Contact:
91 80 2808 2808
Total Funding:
24.41 B INR
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
NextVivo
NextVivo is a biotech company developing an immune organoid technology platform.
Simcere Pharma
Simcere Pharma is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market.
Current Employees Featured
Siddharth Mittal CEO & Managing Director @ Biocon Biologics
CEO & Managing Director
Kiran Mazumdar-Shaw Executive Chairperson @ Biocon Biologics
Executive Chairperson
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-28 | Viatris Biosimilars | Viatris Biosimilars acquired by Biocon Biologics | 3.3 B USD |
Investors List
ADQ
ADQ investment in Venture Round - Biocon Biologics
Goldman Sachs
Goldman Sachs investment in Private Equity Round - Biocon Biologics
Tata Capital
Tata Capital investment in Private Equity Round - Biocon Biologics
True North
True North investment in Private Equity Round - Biocon Biologics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-03-01 | Biocon Biologics promotes Shreehas Tambe as deputy CEO |
| 2019-12-02 | Biocon elevates finance chief Siddharth Mittal as CEO |
Official Site Inspections
http://www.biocon.com Semrush global rank: 1.01 M Semrush visits lastest month: 33.95 K
- Host name: 52.172.34.211
- IP address: 52.172.34.211
- Location: Chennai India
- Latitude: 13.086
- Longitude: 80.2751
- Timezone: Asia/Kolkata
- Postal: 600001
More informations about "Biocon Biologics"
Biocon - India's largest biopharmaceutical company
5 days ago Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs. CONTACT +91 80 2808 2808 . info@biocon.com . About Us. Overview; …See details»
Fact Sheet - Biocon - Global Biopharmaceutical company
Syngene is Biocon’s global innovation-focussed subsidiary that specialises in integrated scientific services. It delivers world-class solutions across the drug …See details»
Biocon - Wikipedia
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, whic…See details»
Org Chart Biocon - The Official Board
Dec 13, 2024 The organizational chart of Biocon displays its 80 main executives including Peter Bains, Jonathan Hunt and Shreehas Tambe. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. Business E …See details»
Biocon Biologics
Biocon Limited Biocon Biologics Limited (90.20%) Biocon Biologics Do Brasil Ltda. (100%) Biosimilars Newco Limited, UK (31.6%) Biocon Biologics Biocon Biologics Canada Inc. (100%) …See details»
Global Biopharmaceutical company - Biocon Biologics
Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third …See details»
Corporate Structure - Biocon
Biocon: Businesses. Recommended sites: Biocon on : Home About Us Investor Relations Media Relations Careers Site Map Contact Us: Our Growth Accelerators Fact Sheet Branded Formulations Biopharmaceuticals Research Services Active Discovery Program: ABLE Karnataka Vision Group on BT Syngene International Biocon AcademySee details»
Biocon - Crunchbase Company Profile & Funding
Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. From discovery to development and commercialisation, Biocon has the defining science, cost-effective drug …See details»
Biocon Fact Sheet - Biopharmaceutical, Diabetology, Cardiology ...
Biocon Limited, publicly listed in 2004, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. ... Biocon Biologics, a subsidiary of Biocon Ltd, is uniquely ...See details»
Biocon's Innovative Matrix
7 rows Biocon Limited is a globally recognized, innovation-led organization that is enabling access to high quality, advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. …See details»
Investors - Corporate Governance - Biocon
Biocon is committed to high standards of Corporate Governance and has in place appropriate structures and reporting systems. Biocon's Board of Directors is headed by an Executive …See details»
Biocon Biologics - LinkedIn
Biocon Biologics | 410,807 followers on LinkedIn. Transforming Healthcare. Transforming Lives. | Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars …See details»
Biocon Biologics Completes One Year as an Integrated Global …
Jan 7, 2025 Shreehas Tambe, CEO & Managing Director, Biocon Biologics Limited, said: “I am proud and excited to celebrate Biocon Biologics’ first-year anniversary as a truly multi-national, …See details»
Who we are - Biocon - Global Biopharmaceutical company
They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely ‘emerging markets’ orientation. We have leveraged India’s value advantage of unmatched scientific talent and cost-competitive manufacturing to deliver scale, speed and quality. By making medicines more easily ...See details»
Biocon - LinkedIn
Biocon | 860,680 followers on LinkedIn. Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical …See details»
Corporate Governance Overview - Biocon - Global …
Biocon’s policies are based on ethical conduct, health, safety and a commitment to building long term sustainable relationships with, and value for, relevant stakeholders. Our corporate …See details»
Biocon Ltd Company Profile - Biocon Ltd Overview - GlobalData
Biocon Ltd (Biocon) is a biopharmaceutical company. It focuses on the research and development of therapies for the treatment of chronic conditions such as cancer, diabetes and autoimmune diseases. It offers a range of active pharmaceutical ingredients (APIs), branded formulations, complex biologics and biosimilars including monoclonal antibodies (MAbs), rh-Insulin, and …See details»
Biocon Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Biocon has 5 employees across 12 locations and ₹141.96 b in annual revenue in FY 2024. See insights on Biocon including office locations, competitors, revenue, financials, …See details»
Biocon Group - LinkedIn
Biocon Group stands resolute in its mission: to make high quality medicines accessible for every patient across the world. With key business verticals spanning Generics, Biosimilars and …See details»
Biocon Profile
Biocon Park, inaugurated in June 2006 by President APJ Abdul Kalam comprises an integrated cluster of research laboratories and manufacturing facilities laid out on a 90 acre expanse in …See details»